Quantcast

Latest Prime Therapeutics LLC Stories

2014-10-10 16:24:32

Provides use, cost forecast based on testing, future treatment rates ST. PAUL, Minn., Oct. 10, 2014 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of Gilead's new, fixed-dose, combination Hepatitis C drug signals another spike in treatment and pharmacy costs for health plans across the country, according to Prime Therapeutics LLC (Prime). "When Sovaldi launched earlier this year, we saw a dramatic increase in prescriptions for the drug," said Peter Wickersham, senior...

2014-10-09 12:29:30

TAMPA, Fla., Oct. 9, 2014 /PRNewswire/ -- The National Association of Specialty Pharmacy (NASP) / Specialty Pharmacy Association of America (SPAARx) announced today that Duane Barnes, Chief Operating Officer (COO) for Prime Therapeutics LLC (Prime), has joined the association's Board of Directors. "This is an exciting time for the specialty pharmacy industry and we are excited to collaborate with board members, like Duane, who can provide valuable insight and support our overall...

2014-10-06 16:27:49

Copay coupons help members afford specialty medicines, may improve adherence, but risk increasing health plan premiums ST. PAUL, Minn., Oct. 6, 2014 /PRNewswire/ -- Today, the journal Health Affairs published its October issue focused on specialty medicines and included an article on copay coupons authored by researchers at Prime Therapeutics LLC (Prime) and Johns Hopkins Bloomberg School of Public Health. Specialty medicines are becoming more common as they're used to treat many complex...

2014-10-06 08:29:11

'Carve-in' Rx benefit model provides integrated data allowing better coordinated care CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Blue Cross Blue Shield Association (BCBSA) and Prime Therapeutics LLC (Prime) today released a study demonstrating clear health benefits and cost savings of including pharmacy benefits as part of an employer's total health insurance benefit package, often referred to as a "carve-in" model. The study examined yearly medical costs of 1.8 million members of Blue...

2014-09-30 08:33:33

ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).(1 )Clinical treatments for opioid dependence include detoxification or maintenance treatment, which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The patterns and costs of these treatments are important when developing and improving care management programs, according to two studies by pharmacy...

2014-09-17 16:27:25

ST. PAUL, Minn., Sept. 17, 2014 /PRNewswire/ -- The United States doesn't have a singular prescription drug problem, we have a series of challenges related to safety, efficacy and cost, according to Peter Wickersham, senior vice president for Integrated Care and Specialty at Prime Therapeutics LLC (Prime). Wickersham will deliver a keynote address, "Solving America's Drug Problem," at the Managed Markets Summit in Scottsdale, Ariz., on Sept. 19, 2014. "Opinions may vary on the causes,...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-08-27 23:10:48

Catamaran’s BriovaRx Specialty Pharmacy and Diplomat Pharmacy, Inc.’s Diplomat University were the two winners of Specialty Pharmacy Solutions’ Innovation Competition, announces the company’s founder and Principal Consultant Bill Sullivan in the August issue of Atlantic Information Services’s Specialty Pharmacy News. Prime Therapeutics received an honorable mention. Washington, DC (PRWEB) August 27, 2014 Catamaran’s BriovaRx Specialty Pharmacy and Diplomat Pharmacy, Inc.’s...

2014-06-17 08:30:17

Despite shift in generics and other less expensive traditional drugs, specialty drug costs drive net ingredient cost and overall commercial pharmacy spend increases ST. PAUL, Minn., June 17, 2014 /PRNewswire/ -- To help make medicine more affordable for the 25 million members it serves, Prime Therapeutics LLC (Prime) starts with delivering an industry-low net cost per prescription*. In 2013, Prime's average net ingredient cost per prescription was $58.99, according to its 2014 Report on...

2014-04-29 08:37:09

ST. PAUL, Minn., April 29, 2014 /PRNewswire/ -- For a second year, Prime Therapeutics LLC (Prime) received top rating for overall customer satisfaction and most likely to recommend for larger pharmacy benefit managers (PBMs) according to a survey conducted by the Pharmacy Benefit Management Institute (PBMI). The top ranking recognized Prime's efforts to help employers get the best value and experience with their health care dollars. The survey included responses from 394 U.S. plan...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.